Origin: Human non-small cell lung cancer, derived from PC-9 cells resistant to osimertinib
Characteristics: Epithelial-like, adherent growth, resistant to third-generation EGFR inhibitors
Applications: Used in lung cancer research, drug resistance studies, and personalized medicine. Ideal for investigating the role of genes in EGFR-targeted therapy resistance and developing novel treatment strategies.
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00047 | ZDHHC11 Knockout cell line (PC9-OR1) | Human | ZDHHC11 | 1:2-1:4 | Negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.